Minerva Surgical (UTRS) Stock Forecast, Price Target & Predictions
UTRS Stock Forecast
Minerva Surgical stock forecast is as follows: an average price target of $5.00 (represents a 4999900.15% upside from UTRS’s last price of -) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
UTRS Price Target
The average price target for Minerva Surgical (UTRS) is $5.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $5.00 to $5.00. This represents a potential 4999900.15% upside from UTRS's last price of -.
UTRS Analyst Ratings
According to 1 Wall Street analysts, Minerva Surgical's rating consensus is 'Buy'. The analyst rating breakdown for UTRS stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Minerva Surgical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 09, 2022 | Matt O'Brien | Piper Sandler | - | - | 85.87% | 4999900.15% |
The latest Minerva Surgical stock forecast, released on Aug 09, 2022 by Matt O'Brien from Piper Sandler, set a price target of $5.00, which represents a 85.87% increase from the stock price at the time of the forecast ($2.69), and a 4999900.15% increase from UTRS last price (-).
Minerva Surgical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | - | - | - |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Minerva Surgical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Minerva Surgical's last price of -. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 09, 2022 | Piper Sandler | Overweight | Overweight | Hold |
Minerva Surgical's last stock rating was published by Piper Sandler on Aug 09, 2022. The company gave UTRS a "Overweight" rating, the same as its previous rate.
Minerva Surgical Financial Forecast
Minerva Surgical Revenue Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Avg Forecast | $15.14M | $14.28M | $14.19M | $13.93M | $13.21M |
| High Forecast | $15.14M | $14.28M | $14.19M | $13.93M | $13.21M |
| Low Forecast | $15.14M | $14.28M | $14.19M | $13.93M | $13.21M |
| # Analysts | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - |
Minerva Surgical's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. UTRS's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Minerva Surgical EBITDA Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - |
| Avg Forecast | $-6.27M | $-5.91M | $-5.87M | $-5.77M | $-5.47M |
| High Forecast | $-6.27M | $-5.91M | $-5.87M | $-5.77M | $-5.47M |
| Low Forecast | $-6.27M | $-5.91M | $-5.87M | $-5.77M | $-5.47M |
| Surprise % | - | - | - | - | - |
undefined analysts predict UTRS's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Minerva Surgical's previous annual EBITDA (undefined) of $NaN.
Minerva Surgical Net Income Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - |
| Avg Forecast | $13.68M | $11.91M | $-6.30M | $-4.79M | $-8.87M |
| High Forecast | $13.68M | $11.91M | $-6.30M | $-4.79M | $-8.87M |
| Low Forecast | $13.68M | $11.91M | $-6.30M | $-4.79M | $-8.87M |
| Surprise % | - | - | - | - | - |
Minerva Surgical's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. UTRS's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Minerva Surgical SG&A Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - |
| Avg Forecast | $15.48M | $14.60M | $14.51M | $14.24M | $13.50M |
| High Forecast | $15.48M | $14.60M | $14.51M | $14.24M | $13.50M |
| Low Forecast | $15.48M | $14.60M | $14.51M | $14.24M | $13.50M |
| Surprise % | - | - | - | - | - |
Minerva Surgical's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to UTRS last annual SG&A of $NaN (undefined).
Minerva Surgical EPS Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - |
| Avg Forecast | $1.54 | $1.34 | $-0.71 | $-0.54 | $-1.00 |
| High Forecast | $1.54 | $1.34 | $-0.71 | $-0.54 | $-1.00 |
| Low Forecast | $1.54 | $1.34 | $-0.71 | $-0.54 | $-1.00 |
| Surprise % | - | - | - | - | - |
According to undefined Wall Street analysts, Minerva Surgical's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to UTRS previous annual EPS of $NaN (undefined).